Health Condition 1: L00-L08- Infections of the skin and subcutaneous tissue
Conditions
Interventions
Intervention1: Fluconazole 1 mg/kg-6 mg/kg: Fluconazole 1 mg/kg-6 mg/kg body weight to be given daily for 6-8 weeks until clinical and mycological cure
Control Intervention1: Not Applicable: Not Appli
Sponsors
Dr Rajeev Sharma
Eligibility
Inclusion criteria
Inclusion criteria: 1. Male or Female Pediatric patients with age up to 18 years old. 2. Pediatric patients who are diagnosed with Tinea infections confirmed by positive KOH
Exclusion criteria
Exclusion criteria: 1. Patients suffering from underlying immunosuppression 2. Patients with Secondarily infected lesions or eczematized lesions 3. Patients who received any type of anti-fungal therapy within last 7 days 4. Patients who applied any other topical agent over the lesions within last 7 days 5. Patients with renal dysfunction 6. Patients with liver dysfunction 7. Patient having history of resistance to Fluconazole
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary objective of this study is to find out efficacy of Fluconazole DT in Pediatric population suffering from Tinea infections Endpoints: ? Time to Clinical Cure ? Time to Mycological Cure- Confirmed by KOH TestTimepoint: Baseline to Subsequent follow up visits (every 2 weeks) | — |
Secondary
| Measure | Time frame |
|---|---|
| The Secondary objective of this trial is to find out safety of Fluconazole DT in Pediatric population suffering from Tinea infections Endpoints: ? Safety of Fluconazole in Pediatric Population ? Any Adverse effect(s) reported by patients during treatmentTimepoint: Baseline to Subsequent follow up visits (every 2 weeks) | — |
Countries
India
Contacts
Public ContactDr Devesh Kumar
Consultant
Outcome results
None listed